quality assurance lims with Segalstad Consulting
Index Articles and information Services Case studies Clients Classes Siri H. Segalstad Site map

What is 21 CFR Part 11?

The 21 CFR Part 11 (often just called Part 11) was created by Food and Drugs Administration in the US www.fda.gov/ora and is a federal law for requirements for computerized systems, their electronic records, and their electronic signatures. It is mandatory for all computer systems in use in the pharmaceutical industry. 21 CFR Part 11 has three types of requirements: Technical features that need to be built into the system; Procedural requirements that the user of the system needs to make; Requirements for validation of all technical features.

The FDA withdrew all their draft guidelines for Part 11 and added one new "Guidance for Industry - Scope and application" in August 2003. This guidance requires the user to use a risk-based approach for which systems are to be included.

Technical requirements include

  • Unique identification of all users in the system. Each user needs his/her own account and password to log in
  • Automatic audit trail created for all entries and changes of data in the system
  • Audit trail includes date, time and ID
  • Old versions of data are never overwritten, but given an "old" status
  • How valid electronic signatures are created
  • Procedural requirements include
  • Validation of the system
  • Large number of topics to be included in SOPs
  • Proof that the SOPs are used accordingly

Who needs to comply with Part 11?

All data created that has an impact on the quality of pharmaceutical products sold in the US shall be in compliance with 21 CFR Part 11. This is not only the pharmaceutical industry itself, but also its suppliers of raw materials, and also all testing and other work performed during outsourcing, if it affects the quality. 21 CFR Part 11 will be a requirement for all industries supplying the US market in the future.

 

21 CFR Part 11 training

There are a number of training possibilities by various training centers catering to the pharmaceutical industry. Segalstad Consulting may also give training on request. 

The most successful training in your company before starting a 21 CFR Part 11 project will be done as a course and workshop lasting several days. The trainers should of course be persons with extensive knowledge of Part 11. The class should cover:

  • Understanding of what the regulation is and its interpretation

  • Assess a couple of systems together in the class

  • Let the participants assess a system under guidance, and discuss along the way, as well as plenary with the rest of the participants in the class

  • Let the participants assess a system without guidance, and discuss the results in plenary with the rest og the participants in the class

Only this way can you be relatively certain that the interpretation is the same for all assessors. And rest asssured: Even after having assessed 100 systems you will find a new variation which will make you wonder if you really had a complete understanding of 21 CFR Part 11......

The Guidance to Part 11 document may help you in your interpretation. It can be retrieved from www.fda.gov/ora/

How do you get compliant systems?

Provided the company is affected, each computer system needs to be assessed for compliance, and brought into compliance. Read more about case studies of Part 11 projects.

It might be wise first to create an inventory of the systems in the company, and create a checklist of items required in 21 CFR Part 11. Most companies probably have an inventory list from Y2K, and this can form a basis for your Part 11 inventory.

1. Assess if the system itself needs to be in compliance

Does it handle GxP data? GxP systems include data that affects the quality of the products.

2. Check each system according to the checklist

Create an overview of where the problems are.

3. Create an action plan for each system

Some problems can be solved internally, others need help from the vendor. Sometimes it is not possible to solve the problems with the system. In that case an other system may take over the job for this system, or a completely new system must replace the existing. In that case, create a URS.

Solutions may include:

  • Writing to the vendor and hope that he can help you with the technical non-compliance in the system. This may be incorporated in the next version.

  • Create or change SOPs to include all procedural requirements in 21 CFR Part 11. This should be done without delay.

  • Validate all technical requirements set forth in Part 11. Chances are that even if your system was validated, some of these issues were missing during the testing. Validation activites should be done without delay.

4. Create an overall action plan for your systems

It is probably not possible to fix all problems quickly, as there are usually limited resources to do so. In that case, make a priority list of the systems to be worked on. Priorities are based risks: How important each system is for the company and how much it is used. Start with the top system and work down the list. 


Want to know more?

Publications:

Segalstad: The WWW (Who-Why-What) of 21 CFR Part 11 Electronic Records and Electronic Signatures, European Pharmaceutical Review Vol. 5 Issue 2 (2000) 69-74. Also published in American Pharmaceutical Review Vol.3 Issue 4 Winter 2000-2001 (84-87)

Segalstad: Elektroniske data og elektronisk signatur, (electronic data and electronic signatures) Kjemi, April 2001 (9-12)

Segalstad: Testplans according to 21 CFR Part 11, International Validation Technology (in press, probably in fall 2003 issue)

Classes:

Classes are offered on request, tailored to needs for in-house training in your company.

Websites:

21 CFR Part 11: www.fda.gov/ora


Go to Index

Sub menu Articles and Information: 

21 CFR Part 11

Standards and regulations

Validation Plan

Qualifications

LIMS

User Requirements Specification URS

System selection

Supplier audits

IT project organization

Live system organization 

 



Segalstad Consulting AS
PO Box 15 Kjelsås, 0411 Oslo, Norway * Tel: +47 2223 8005 * Fax: +47 2223 8581 * Email: Siri@Segalstad.com * 

Web: www.LIMSconsultant.com    www.segalstad.com